Clarivate to sell life sciences unit to Altaris for $600 million
Clarivate Plc (NYSE: CLVT) has agreed to divest its Life Sciences & Healthcare segment to Altaris LLC, a healthcare-focused investment ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
